Infection and Tumour Antigen Cellular Therapy
NCT02895412
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myelocytic, Acute
Interventions
BIOLOGICAL:
Donor-derived WT1-CTL and P-CTL
Sponsor
University of Sydney